Who
Hing C. Wong
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, HCW Biologics.
In numbers
- Trades disclosed
- 36
- Buys
- 23
- Sells
- 0
- Bought
- $8.1M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Jul 2021
- Last trade
- 29 Jul 2026
- Last filed
- 31 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 31 Jul 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $60K23,210 at $2.59 | filing |
| 29 Jul 2026filed 31 Jul 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $60K23,210 at $2.59 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $160K113,879 at $1.41 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —113,879 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —113,879 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $161K113,879 at $1.41 | filing |
| 16 May 2025filed 20 May 2025 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $60K8,054 at $7.45 | filing |
| 8 May 2025filed 9 May 2025 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $2.4M92,500 at $26.00 | filing |
| 7 May 2025filed 9 May 2025 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —46,250 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Code A | $1.0M739,288 at $1.40 | filing |
| 14 Sep 2023filed 18 Sep 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $3,7441,800 at $2.08 | filing |
| 2 Jun 2023filed 2 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $1,232800 at $1.54 | filing |
| 1 Jun 2023filed 2 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $1,296800 at $1.62 | filing |
| 31 May 2023filed 1 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $3,1002,000 at $1.55 | filing |
| 30 May 2023filed 1 Jun 2023 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $4,6503,000 at $1.55 | filing |
| 9 Sep 2022filed 12 Sep 2022 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $16K6,000 at $2.70 | filing |
| 8 Sep 2022filed 12 Sep 2022 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $11K4,000 at $2.67 | filing |
| 7 Sep 2022filed 7 Sep 2022 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $15K6,000 at $2.58 | filing |
| 2 Sep 2022filed 7 Sep 2022 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $10K4,000 at $2.55 | filing |
| 10 Jun 2022filed 13 Jun 2022 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $3,3291,520 at $2.19 | filing |
News
Financial Survey: HCW Biologics (NASDAQ:HCWB) vs. Cardio Diagnostics (NASDAQ:CDIO)HCWB · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Hing C. Wong; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.